Dengue Virus Subtype 4 Envelope 15kDa, C-Terminal (Domain III) Recombinant, Dengue Envelope-4 15kDa, 500ug
Dengue Virus Subtype 4 Envelope 15kDa, C-Terminal (Domain III) Recombinant, Dengue Envelope-4 15kDa, 500ug
CAT No.BT-DEN-012 |
Dengue Virus Subtype 4 Envelope 15kDa, C-Terminal (Domain III) Recombinant, Dengue Envelope-4 15kDa, 500ug |
Sequence
SYTMCSGKFSIDKEMAETQHGTTVVKVKYEGAGAPCKVPIEIRDVNKEKV
VGRIISSTPFAEYTNSVTNIELEPFGDSYIVIGVGDSALTLHWFRKGSSIV.
Applications
Each laboratory should determine an optimum working titer for use in its particular application.
Description
The E.coli derived recombinant 12kDa protein is genetically engineered peptide which is derived from Dengue Type-2 envelope III domain immunodeterminant regions. The expressed dengue envelope Type-2 III domain peptide has 100 amino acids covering domain III region from amino acids 300-400, and is fused with a 6 His Tag. This peptide is particularly important for diagnostic and vaccine development as it contains multiple serotypes, neutralizing epitopes and receptor binding domain.
Method
Purified by proprietary chromatographic technique.
Purity
Protein is >95% pure as determined by 10% PAGE (coomassie staining).
Stability
Five years frozen. One month in solution at room temperature.
Storage
Protein is shipped at ambient temperature.
Upon arrival, Store at -20¡ãC.
Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Product features
Product features
Materials and care
Materials and care
Merchandising tips
Merchandising tips
Share


